Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Paul W.A. Janssen"'
Autor:
Sigrid Sandner, Björn Redfors, Dominick J. Angiolillo, Katia Audisio, Stephen E. Fremes, Paul W.A. Janssen, Alexander Kulik, Roxana Mehran, Joyce Peper, Marc Ruel, Jacqueline Saw, Giovanni Jr Soletti, Andrew Starovoytov, Jurrien M. ten Berg, Laura M. Willemsen, Qiang Zhao, Yunpeng Zhu, Mario Gaudino
Publikováno v:
JAMA. 328(6)
The role of ticagrelor with or without aspirin after coronary artery bypass graft surgery remains unclear.To compare the risks of vein graft failure and bleeding associated with ticagrelor dual antiplatelet therapy (DAPT) or ticagrelor monotherapy vs
Autor:
Albert H.M. van Straten, Chris M Hackeng, Marc A. Brouwer, Dean R P P Chan Pin Yin, Marieke E. Gimbel, Kasper F Beukema, Hendrik W. van Es, Mohamed A. Soliman-Hamad, Jan G.P. Tijssen, Laura M Willemsen, Martin J. Swaans, Clemens von Birgelen, Uday Sonker, Jurriën M. ten Berg, Benno J. Rensing, Joyce Peper, Vera H.M. Deneer, Margreet W.A. Bekker, Johannes C. Kelder, Pim van der Harst, Edgar J. Daeter, Patrick Klein, Eline A Vlot, Paul W.A. Janssen
Publikováno v:
Circulation, 142(19), 1799-1807. LIPPINCOTT WILLIAMS & WILKINS
Circulation, 142, 1799-1807
Circulation, 142, 19, pp. 1799-1807
Circulation, 142(19), 1799-1807. Lippincott Williams & Wilkins
Circulation, 142(19), 1799-1807. Lippincott Williams and Wilkins
Circulation, 142, 1799-1807
Circulation, 142, 19, pp. 1799-1807
Circulation, 142(19), 1799-1807. Lippincott Williams & Wilkins
Circulation, 142(19), 1799-1807. Lippincott Williams and Wilkins
BACKGROUND: Approximately 15% of saphenous vein grafts (SVGs) occlude during the first year after coronary artery bypass graft surgery (CABG) despite aspirin use. The POPular CABG trial (The Effect of Ticagrelor on Saphenous Vein Graft Patency in Pat
Autor:
Laura M. Willemsen, Eline A. Vlot, Paul W.A. Janssen, Claire D. Visser, Kai Zheng, Johannes C. Kelder, Peter G. Noordzij, Erik‐Jan van den Dool, Patrick Klein, Christian M. Hackeng, Jurrien M. ten Berg
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 8, Pp n/a-n/a (2021)
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 8, Pp n/a-n/a (2021)
Background Aspirin is important for preventing thrombotic events but also increases bleeding complications. Minimizing bleeding while preventing thrombotic events remains challenging in patients undergoing coronary artery bypass grafting (CABG). Esta
Autor:
Paul W.A. Janssen, Jurriën M. ten Berg
Publikováno v:
JACC: Cardiovascular Interventions. 13:631-633
Type I IFN (IFN-I) is thought to be rapidly internalized and degraded following binding to its receptor and initiation of signaling. However, many studies report the persistent effects mediated by IFN-I for days or even weeks, both ex vivo and in viv
Autor:
Vera H.M. Deneer, Renicus S Hermanides, Carmine Morisco, Richard M. Tjon Joe Gin, Gerrit J.A. Vos, Arend Mosterd, Pim van der Harst, Daniel M.F. Claassens, Jean-Paul R. Herrman, Johannes C. Kelder, Willem Dewilde, Paul W.A. Janssen, Bakhtawar K. Mahmoodi, Arnoud W J van 't Hof, Jurriën M. ten Berg, Folkert W. Asselbergs, Thomas O. Bergmeijer, Emanuele Barbato
Publikováno v:
Circulation-Cardiovascular interventions, 14(4):009434, 402-411. LIPPINCOTT WILLIAMS & WILKINS
Circulation. Cardiovascular interventions, 14(4). Lippincott Williams and Wilkins
Circulation: Cardiovascular Interventions, 14(4), 402. Lippincott Williams and Wilkins Ltd.
Circulation-Cardiovascular Interventions, 14(4):009434, 402-411. LIPPINCOTT WILLIAMS & WILKINS
Circulation. Cardiovascular interventions, 14(4). Lippincott Williams and Wilkins
Circulation: Cardiovascular Interventions, 14(4), 402. Lippincott Williams and Wilkins Ltd.
Circulation-Cardiovascular Interventions, 14(4):009434, 402-411. LIPPINCOTT WILLIAMS & WILKINS
Background: Guidelines favor ticagrelor or prasugrel over clopidogrel in patients with myocardial infarction. However, the POPular Genetics trial (Patient Outcome After Primary Percutaneous Coronary Intervention [PCI]) showed that in patients with pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f54ef6016a26fcea7ac724e7cf6c3723
https://research.rug.nl/en/publications/c88d7bed-0522-46be-abfa-3331f07b3fe4
https://research.rug.nl/en/publications/c88d7bed-0522-46be-abfa-3331f07b3fe4
Autor:
Giovanni Amoroso, Paul W.A. Janssen, Thomas O. Bergmeijer, Wouter W. Nolet, Dionne J. van Kessel, Marieke E. Gimbel, Joanna J. Wykrzykowska, Willem Dewilde, Johannes C. Kelder, Ton Heestermans, Jurriën M. ten Berg, Thea C. Godschalk
Publikováno v:
Journal of interventional cardiology, 31(2), 159-169. Wiley-Blackwell
Objectives: The aim of this study was to determine predictors of very late stent thrombosis (VLST; >1 year after stenting), and to evaluate whether addition of these predictors to the dual antiplatelet therapy (DAPT) score would improve the ability t
Autor:
T. T. D. Le, Nicoline J. Breet, Christian M. Hackeng, Johannes C. Kelder, J. M. ten Berg, Thomas O. Bergmeijer, Paul W.A. Janssen, Thea C. Godschalk
Publikováno v:
Journal of Thrombosis and Haemostasis. 15:618-623
Essentials Platelet reactivity is correlated with thrombotic risk after percutaneous coronary intervention (PCI). Hematocrit (HCT) is associated with platelet reactivity as measured with the VerifyNow P2Y12 assay. We tested a formula proposed to corr
Autor:
Christian M. Hackeng, Laura M Willemsen, Eline A Vlot, Paul W.A. Janssen, Peter G. Noordzij, Johannes C. Kelder, Geoffrey T.L. Kloppenburg, Jurriën M. ten Berg, Eric P.A. van Dongen
Publikováno v:
Platelets. 30(8)
Postoperative coagulopathic bleeding is common in cardiac surgery and associated with increased morbidity and mortality. Platelet function is affected by multiple factors, including patient and procedural characteristics. Point-of-care (POC) multiple
Autor:
Marylyn D. Ritchie, Paul W.A. Janssen, Teri E. Klein, Anthonius de Boer, Olaf H. Klungel, Christian M. Hackeng, Johannes C. Kelder, Icpc Investigators, Alfi Yasmina, Jurriën M. ten Berg, Li Gong, Thomas O. Bergmeijer, Vera H.M. Deneer, Shefali S. Verma, Gerrit J.A. Vos
Publikováno v:
Genes
Genes, Vol 11, Iss 1068, p 1068 (2020)
Volume 11
Issue 9
Genes, 11(9), 1. Multidisciplinary Digital Publishing Institute (MDPI)
Genes, Vol 11, Iss 1068, p 1068 (2020)
Volume 11
Issue 9
Genes, 11(9), 1. Multidisciplinary Digital Publishing Institute (MDPI)
This study aims to determine whether genetic variants that influence CYP3A4 expression are associated with platelet reactivity in clopidogrel-treated patients undergoing elective percutaneous coronary intervention (PCI), and to evaluate the influence
Autor:
Robert A Lichtveld, A. Mosterd, Thea C. Godschalk, Thomas O. Bergmeijer, Mathijs van Oevelen, Jurriën M Ten Berg, Paul W.A. Janssen, Gilles Montalescot, Michiel Voskuil, Johannes C. Kelder
Publikováno v:
TH Open: Companion Journal to Thrombosis and Haemostasis
TH Open, Vol 02, Iss 04, Pp e357-e368 (2018)
TH open : companion journal to thrombosis and haemostasis, 2(4), e357
TH Open, Vol 02, Iss 04, Pp e357-e368 (2018)
TH open : companion journal to thrombosis and haemostasis, 2(4), e357
Objectives The objective of this registry was to study the safety of prehospital initiation of ticagrelor compared with clopidogrel. Background Ticagrelor has replaced clopidogrel in many hospitals as the routinely used antiplatelet drug in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80104c54bf17eace2a099be0f927b945
https://dspace.library.uu.nl/handle/1874/383573
https://dspace.library.uu.nl/handle/1874/383573